Audience: Practitioners

If you do not find what you are looking for try searching with a different term or contact us.

What is Harm Reduction? (Poster)

This poster identifies some of the most common harm reduction methods in an attempt to normalize the term “harm reduction” and broaden the definition.

Opioid Use Disorder

This activity focuses on the critical evaluation and management of opioid use disorder (OUD), a pervasive condition significantly diminishing patients’ quality of life and contributing to a widespread epidemic in the United States.

Introduction to Crisis Response Systems & Suicide Prevention Online Course

Implementing an effective Crisis Response System benefits individuals, families and communities.  This training will provide an overview of the goals and strategies to consider when designing and implementing an effective Crisis Response System while also considering how to structure services and approaches to best meet the needs of individuals who experience a mental health crisis and how to respond to individuals at risk of suicide.

“It’s called overamping”: experiences of overdose among people who use methamphetamine” by University of Nevada, Reno, School of Public Health & University of New Mexico Health Sciences

The USA is experiencing increases in methamphetamine use and methamphetamine-related or attributed deaths. In the current study, we explore qualitative narratives of methamphetamine overdose and strategies used by people who use drugs to reduce the undesirable effects associated with methamphetamine use.

Filter Magazine – Why New 12-Step Members May Avoid Carrying Naloxone by Jeanette Bowles, PhD, University of California San Diego, Division of Infectious Diseases and Global Public Health

For new members of 12-step programs like Alcoholics Anonymous and Narcotics Anonymous, naloxone can still seem like a symbol of drug use, according to new research. This can cause some people looking to kick drugs through these large abstinence-based fellowships—NA, for example, holds 70,000 weekly meetings in 144 countries, according to a 2018 survey—to decline to carry the overdose-reversal drug, seeing it as a relic of a past life.

The Mobile Emergency Recovery Intervention Trial (MERIT)

The Mobile Emergency Recovery Intervention Trial (MERIT) is a grant-funded research study that is evaluating the effectiveness and long-term outcomes of an ER-based intervention for opioid overdose patients treated in Nevada’s Emergency Departments (EDs). The research is currently ongoing.

Starting medication for opioid use disorder prior to prison release substantially reduces overdose deaths

Individuals with opioid use disorder being released from prison are at particularly high risk for fatal overdose, yet virtually no U.S. correctional facilities initiate or continue medications for addiction treatment that would protect people against overdose following release from prison. This study explored whether a novel program in the state of Rhode Island that continued inmates’ opioid use disorder medications led to decreased drug overdoses. 

A Beginner’s Guide to Gambling and Opioid Use Disorder for Behavioral Health Providers

“Gambling disorder (GD) is a psychiatric condition featuring recurrent, maladaptive gambling behavior that leads to clinically significant distress. GD was reclassified recently into the “Substance-Related and Addictive Disorders” group of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)1, a first for a behavioral addiction” (Menchon, et al., 2018; American Psychiatric Association, 2013). While gambling is a harmless activity for most people who gamble, some – approximately one percent of the U.S. population – develop severe gambling disorder (Kessler, et al., 2008; Alegria, et al., 2009; Shaffer, et al., 1999). Some populations have higher rates of disordered gambling, such as youth and young adults, 6-9%, some ethnic and racial minorities, and those with other addictive behaviors or mental health disorders (Barnes, et al., 2010; Barry, et al., 2011; Kessler, et al., 2008; Petry, et al., 2005).

Care Considerations for Addressing Substance Use and the Opioid Epidemic Among Older Adult Populations

Substance Use disorders in Older Adults is a growing problem not only in the United States, but throughout the developed world. This may be particularly relevant among people from the Baby Boomer generation, born between 1946 and 1964. The use of an artificial cut off age of 65 years of age as the definition of elderly or old is somewhat arbitrary and this will be discussed. The presentation will look at the prevalence of substance use among older people with an added focus on opioid epidemiology. It will also provide an overview for screening and identifying substance use within this population group. Additionally, a broad biopsychosocial framework and sociohistorical lens will be utilized to analyze risk factors and vulnerabilities for substance use among older people. The presentation will conclude with care considerations that integrate psychosocial aspects of well-being and reinforce the importance of psychotherapeutic interventions.

Gambling and Opioid Use Disorder: Intersections and Integration

Clients in treatment for Opioid Use Disorders, particularly those in medication assisted treatment have been found to have extremely high rates of co-occurring gambling disorder. This online training will review the research on the co-occurrence of gambling disorder and opioid use disorder, focusing on both quantitative and qualitative research that has sought to understand this connection. Transcripts from clients in medication assisted treatment will be used to illustrate the role gambling plays in their lives and recoveries. Strategies for screening and treating gambling issues among those in treatment for opioid use disorders will be discussed.

Medications for Opioid Use Disorder During Pregnancy

This self-paced, online course offers an evidence based/informed review of buprenorphine vs methadone during pregnancy and recommendations for providers/organizations that treat pregnant, postpartum, and reproductive age patients.

State Harm Reduction Strategies to Address Substance Use and Related Outcomes Among Women of Childbearing Age

Nevada’s Substance Abuse Prevention and Treatment Agency (SAPTA) is housed under the Nevada Division of Public and Behavioral Health (DPBH) within the Department of Health and Human Services (DHHS). The Maternal, Child, and Adolescent Health (MCAH) program also resides within DPBH. MCH entities and providers have had a long-standing collaborative relationship with SAPTA, which has strengthened over the past two years with shifting substance use trends. Alcohol, tobacco, and opioids remain the most used substances in Nevada. Deaths involving synthetic opioids other than methadone (including fentanyl and fentanyl analogs) continue to rise to a rate of 9.9 per 100,000 individuals in 2018, while prescription opioid-related overdose deaths have declined to a rate of 4.6 (NIDA, 2020)

Nevada Use of STR/SOR Grant Funds to Address the Opioid Crisis

The Substance Abuse and Mental Health Services Administration (SAMHSA) administers the State Targeted Response to the Opioid Crisis (STR) and State Opioid Response (SOR) grant programs. These grants aim to address the opioid crisis by increasing access to treatment, reducing unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment, and recovery activities for opioid use disorder (OUD) in the States. States received a total of $500 million for each of FY 2017 and FY 2018 through STR. Additionally, in FY 2018, States received an additional $1 billion in new funding through the SOR grants. In FY 2019, States received $1.5 billion through SOR. Eligible applicants for both STR and SOR are the State alcohol and drug agencies.

Provider Training Needs Assessment

In February 2018, a total of 1,074 healthcare providers responded to a needs assessment designed to guide development of opioid-related trainings to facilitate successful implementation of Nevada’s Opioid State Targeted Response.

Medication-Assisted Treatment (MAT) Services for Opioid Dependence Billing Instructions Guide

The Division of Health Care Financing and Policy has taken action to address the opioid crisis by updating Nevada Medicaid policy and opening Medication-Assisted Treatment (MAT)-related evaluation and management (E/M) codes for billing by Nevada Medicaid providers effective with dates of service on or after January 1, 2020. In addition to MAT related E/M codes, Nevada Medicaid opened Screening, Brief Intervention, Referral to Treatment (SBIRT) codes to assist providers in performing screening services to recipients at risk or struggling with Substance Use Disorder (SUD).

ATTC Educational Packages for Opioid Use Disorders

The Addiction Technology Transfer Center (ATTC) Network Coordinating Office (NCO), funded by the Substance Abuse and Mental Health Services (SAMHSA), has designed three competency-based guides to raise awareness of resources available to build the capacity of the workforce to address the opioid crisis. The digital guides are relevant to psychologists, counselors, social workers, peer support workers, and other behavioral health professionals who intersect with people at risk for misuse of, or who are already misusing, opioids.

In My Own Words

A compilation of essays by individuals supported by Medication-Assisted Treatment in long-term recovery.

TIP 63: Medications for Opioid Use Disorder

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.